Literature DB >> 1311083

Synthesis of receptor antagonists of neuropeptide Y.

K Tatemoto1, M J Mann, M Shimizu.   

Abstract

We report the synthesis of receptor antagonists of neuropeptide Y (NPY) by a strategy based on synthesis of mixtures of analogs and the subsequent isolation and identification of receptor antagonists from these mixtures. After screening a series of mixtures of NPY analogs by using an NPY antagonist assay, two potent receptor antagonists, designated PYX-1 and PYX-2, were isolated from an antagonist-containing mixture. Structural analysis revealed these analogs to be Ac-[3-(2,6-dichlorobenzyl)Tyr27, D-Thr32]NPY-(27-36) amide and Ac-[3-(2,6-dichlorobenzyl)Tyr27,36,D-Thr32]NPY-(27-36) amide, respectively. The receptor antagonists inhibited release of intracellular calcium elicited by NPY in human erythroleukemia cells and displaced 3H-labeled NPY from NPY receptors in rat brain membrane. The approach of screening and identifying useful analogs from synthetic mixtures may significantly reduce the time and resources previously required for development of receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311083      PMCID: PMC48411          DOI: 10.1073/pnas.89.4.1174

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Biologically active neuropeptide Y analogs.

Authors:  J H Boublik; M A Spicer; N A Scott; M R Brown; J E Rivier
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

Review 2.  Strategy and tactics in protein chemistry.

Authors:  B S Hartley
Journal:  Biochem J       Date:  1970-10       Impact factor: 3.857

3.  Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.

Authors:  K Tatemoto; M Carlquist; V Mutt
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

4.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

5.  Neuropeptide Y (18-36) is a competitive antagonist of neuropeptide Y in rat cardiac ventricular membranes.

Authors:  A Balasubramaniam; S Sheriff
Journal:  J Biol Chem       Date:  1990-09-05       Impact factor: 5.157

6.  Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion.

Authors:  K Tatemoto
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

7.  An acid-labile anchoring linkage for solid-phase synthesis of C-terminal peptide amides under mild conditions.

Authors:  F Albericio; G Barany
Journal:  Int J Pept Protein Res       Date:  1987-08

8.  Acid stability of several benzylic protecting groups used in solid-phase peptide synthesis. Rearrangement of O-benzyltyrosine to 3-benzyltyrosine.

Authors:  B W Erickson; R B Merrifield
Journal:  J Am Chem Soc       Date:  1973-05-30       Impact factor: 15.419

9.  Chemical determination of polypeptide hormones.

Authors:  K Tatemoto; V Mutt
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

10.  Neuropeptide Y mobilizes Ca2+ and inhibits adenylate cyclase in human erythroleukemia cells.

Authors:  H J Motulsky; M C Michel
Journal:  Am J Physiol       Date:  1988-12
View more
  6 in total

1.  [(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors.

Authors:  Y Dumont; R Quirion
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

2.  The neuropeptide Y antagonist PYX2 decreases lordosis behavior.

Authors:  J E Thornton; S Carson
Journal:  Endocrine       Date:  1995-11       Impact factor: 3.633

3.  Effects of neuropeptide Y (NPY) and NPY agonists on lordosis in the female guinea pig.

Authors:  J E Thornton; L Holcomb; S Leupen; L Kimbrough
Journal:  Endocrine       Date:  1996-10       Impact factor: 3.633

4.  Failure of the putative neuropeptide Y antagonists, benextramine and PYX-2, to inhibit Y2 receptors in rat isolated prostatic vas deferens.

Authors:  S Palea; M Corsi; J M Rimland; D G Trist; E Ratti
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

5.  Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226.

Authors:  R Abounader; J G Villemure; E Hamel
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

6.  High-affinity neuropeptide Y receptor antagonists.

Authors:  A J Daniels; J E Matthews; R J Slepetis; M Jansen; O H Viveros; A Tadepalli; W Harrington; D Heyer; A Landavazo; J J Leban; A Spaltenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.